首页> 外文会议>American Peptide Symposium >The Structural Determinants of GPCR Binding and Activations; Insights from Mutagenesis and Molecular Modeling Studies of the Human Angiotensin II Type 1 (hATl) Receptor
【24h】

The Structural Determinants of GPCR Binding and Activations; Insights from Mutagenesis and Molecular Modeling Studies of the Human Angiotensin II Type 1 (hATl) Receptor

机译:GPCR结合和激活的结构决定因素; 来自人血管紧张素II型1(HATL)受体的诱变和分子建模研究的见解

获取原文

摘要

The G protein coupled receptors (GPCRs) are seven transmembrane domains (TMD) proteins involved in the mediation of environmental stimuli across the plasma membrane. Determination of the structural basis of GPCR ligand binding and activation is of primary importance in drug development. However, their structural analysis remains a considerable challenge and the only GPCR 3D structure experimentally determined to date is that of the bovine rhodopsin. The mutation of an Asn residue in TMD 3, conserved in 29% of all family A GPCRs, has been reported to induce constitutive activation of several GPCRs, such as the PAF, B2, CXCR4, and hATl receptors. Rhodopsin-based homology models of the hAT1 receptor revealed an interaction between this residue (N111~(3.35), Ballesteros numerotation in superscript) and a conserved Asp residue in TMD 2, D74(2.50) (Fig. 1A). Interestingly, mutation of D74 impairs isomerization of the receptor toward an active form capable of activating the G_q protein. We hypothesized that the interaction between D74 and Nl 11 is crucial for the stabilization of the inactive form of hATl in the absence of agonist and that this interaction maintains the GELTA G of isomerisation (DELTA G_(iso)) within a few kcal/mol in order to allow a small population of receptors to adopt the active form. We generated D74N and N1 11G mutant hATl receptors as controls, as well as two novel mutant receptors, D74N/N111D and D74N/N111G. After verifying the structural integrity of the mutant receptors by saturation and competition studies with angiotensin II (Ang II), their ability to activate G_q was assessed by IP production analysis (Fig. 1B).
机译:G蛋白偶联受体(GPCR)是七个跨膜结构域(TMD)蛋白,参与在血浆膜上的环境刺激的中介。测定GPCR配体结合和活化的结构基础是药物发育的主要重要性。然而,它们的结构分析仍然是一个相当大的挑战,并且实验确定迄今为止的唯一GPCR 3D结构是牛罗多蛋白的结构。据报道,TMD 3中TMD 3中ASN残基的突变,尤其是GPCR的29%,以诱导几种GPCR的组成型激活,例如PAF,B2,CXCR4和HATL受体。哈科蛋白素的HAT1受体的同源模型揭示了该残余物(N111〜(3.35),上标的倒置之间的相互作用,在TMD 2,D74(2.50)中的保守asp残基(图1a)。有趣的是,D74的突变将受体的异构化朝向能够激活G_Q蛋白的活性形式。我们假设D74和N111之间的相互作用对于在没有激动剂的情况下稳定无活性形式的HATL的关键并且该相互作用将GELTA G的异构化(Delta G_(ISO))保持在几千卡/摩尔中为了允许小群体受体采用活性形式。我们生成D74N和N1 11G突变体HATL受体作为对照,以及两种新型突变受体,D74N / N111D和D74N / N111G。通过饱和度和血管紧张素II(Ang II)的竞争研究验证突变受体的结构完整性,通过IP生产分析评估它们激活G_Q的能力(图1B)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号